Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

NDRA

ENDRA Life Sciences Inc

Apr 18 • 04:00PM ET

0.2334

Dollar change +0.0026
Percentage change 1.13	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.90	Insider Own	1.41%	Shs Outstand	11.04M	Perf Week	-36.92%
Market Cap	2.58M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	10.88M	Perf Month	-77.98%
Income	-10.06M	PEG	-	EPS next Q	-	Inst Own	1.19%	Short Float	0.28%	Perf Quarter	-78.78%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-5.86%	Short Ratio	0.17	Perf Half Y	-77.34%
Book/sh	0.54	P/B	0.43	EPS next Y	-	ROA	-125.53%	Short Interest	0.03M	Perf Year	-87.32%
Cash/sh	0.26	P/C	0.91	EPS next 5Y	-	ROE	-156.42%	52W Range	0.22 - 2.79	Perf YTD	-88.99%
Dividend Est.	-	P/FCF	-	EPS past 5Y	48.47%	ROI	-171.94%	52W High	-91.63%	Beta	1.17
Dividend TTM	-	Quick Ratio	3.36	Sales past 5Y	-20.00%	Gross Margin	-	52W Low	5.61%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	3.36	EPS Y/Y TTM	58.90%	Oper. Margin	0.00%	RSI (14)	18.73	Volatility	19.67% 15.76%
Employees	21	Debt/Eq	0.07	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	11.00
Option/Short	No / Yes	LT Debt/Eq	0.03	EPS Q/Q	86.46%	Payout	-	Rel Volume	0.36	Prev Close	0.23
Sales Surprise	-	EPS Surprise	52.78%	Sales Q/Q	-	Earnings	Mar 28 AMC	Avg Volume	176.49K	Price	0.23
SMA20	-56.07%	SMA50	-73.61%	SMA200	-79.30%	Trades		Volume	64,339	Change	1.13%

Apr-01-24 09:59AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.50%
Mar-29-24 06:21AM	Q4 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	NDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q4 2023 (InvestorPlace) -29.29%
04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-24 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 (Business Wire) -8.76%
08:00AM	Loading…
Feb-27-24 08:00AM	ENDRA Life Sciences Installs First TAEUS System in the UK (Business Wire)
Feb-21-24 08:00AM	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System (Business Wire)
Feb-14-24 08:30AM	ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe (Business Wire)
Nov-29-23 08:00AM	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology (Business Wire)
Nov-27-23 08:00AM	ENDRA Life Sciences to Participate in The Benchmark Companys 12th Annual Discovery One-on-One Investor Conference (Business Wire)
Nov-15-23 01:23PM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Nov-08-23 08:00AM	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents (Business Wire)
Nov-07-23 04:05PM	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 (Business Wire)
Nov-06-23 08:00AM	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLDs The Liver Meeting 2023 (Business Wire)
08:00AM	Loading…
Sep-07-23 08:00AM	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 (Business Wire)
Aug-30-23 08:00AM	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA (Business Wire) +6.31%
Aug-23-23 08:00AM	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents (Business Wire)
Aug-20-23 11:20AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-15-23 06:49AM	Q2 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -8.37%
Aug-14-23 04:05PM	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update (Business Wire)
01:30PM	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA (Business Wire)
Aug-01-23 08:00AM	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023 (Business Wire)
Jul-12-23 05:15PM	Domino's Pizza teams up with Uber for food delivery partnership (Yahoo Finance Video)
03:27PM	Stocks to Watch Wednesday: Domino's, Coty, Activision, Lucid (The Wall Street Journal)
02:42PM	Analyst Report: Domino's Pizza, Inc. (Morningstar Research)
02:01PM	Domino's stock jumps on partnership with Uber Eats (Yahoo Finance)
12:31PM	Dominos Pizza Is Todays Hottest Stock (The Wall Street Journal)
10:30AM	Domino's Pizza stock jumps on delivery partnership with Uber (Yahoo Finance Video)
09:42AM	Dominos Pizza Is This Mornings Hottest Stock (The Wall Street Journal)
07:05AM	Loading…
07:05AM	Domino's® Introduces a New Way to Order Using Uber Eats Marketplace (PR Newswire)
Jul-06-23 04:45PM	ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023 (Business Wire)
Jun-07-23 08:00AM	Study Highlighting ENDRA Life Sciences TAEUS Technology to be Presented at EASL International Liver Congress 2023 (Business Wire) +5.33%
May-15-23 04:05PM	ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update (Business Wire) -8.57%
May-04-23 08:00AM	ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023 (Business Wire) +8.70%
May-02-23 04:01PM	ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Securities (Business Wire) +17.24%
Apr-28-23 08:00AM	ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering (Business Wire) +24.03%
Mar-17-23 05:00AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.00%
Mar-15-23 10:32AM	Q4 2022 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-23 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-07-23 04:05PM	ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023 (Business Wire)
Dec-08-22 09:55AM	Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher (Zacks) +6.79%
Dec-05-22 08:00AM	ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split (Business Wire) -12.10%
Nov-14-22 04:05PM	ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Nov-09-22 08:00AM	ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022 (Business Wire) -7.51%
Oct-25-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents (Business Wire)
Oct-04-22 08:00AM	ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference (Business Wire)
Sep-29-22 04:05PM	ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks (Business Wire)
Sep-06-22 08:00AM	ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences (Business Wire)
Aug-24-22 08:40AM	ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System (Business Wire) +11.62%
Aug-15-22 04:30PM	Edited Transcript of NDRA.OQ earnings conference call or presentation 15-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-08-22 10:16AM	Here's Why ENDRA Life Sciences (NASDAQ:NDRA) Must Use Its Cash Wisely (Simply Wall St.)
Aug-04-22 08:00AM	ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-02-22 08:00AM	ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices (Business Wire)
Aug-01-22 08:00AM	ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference (Business Wire) +14.63%
Jul-11-22 08:00AM	ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System (Business Wire)
Jun-28-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent (Business Wire) +7.11%
Jun-08-22 08:00AM	ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference (Business Wire) +6.97%
May-25-22 08:00AM	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent (Business Wire)
May-16-22 08:00AM	ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference (Business Wire)
May-12-22 04:05PM	ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-10-22 08:00AM	ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System (Business Wire)
May-02-22 08:00AM	ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022 (Business Wire)
Apr-21-22 08:00AM	ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility (Business Wire)
Mar-31-22 08:00AM	ENDRA Life Sciences Achieves Key Quality Management System Certification (Business Wire)
Mar-30-22 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +8.37%
09:12AM	ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents (Business Wire)
Mar-22-22 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022 (Business Wire)
Mar-09-22 08:00AM	ENDRA Life Sciences to Participate in Two March Investor Conferences (Business Wire) +11.02%
Mar-08-22 08:00AM	ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent (Business Wire)
Feb-15-22 08:55AM	The Stock Day Podcast Hosted ENDRA Life Sciences Inc. to Discuss the Potential of its Thermo Acoustic Enhanced UltraSound (TAEUS(R)) (Newsfile) +11.59%
Feb-11-22 08:00AM	ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents (Business Wire) -9.28%
Feb-10-22 07:10AM	ENDRA Life Voluntarily Withdraws 510(k) Application For Liver Fat Measuring System (Benzinga) -20.30%
Feb-09-22 04:05PM	ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System (Business Wire)
Jan-24-22 08:15AM	ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership (Business Wire)
Jan-05-22 07:00AM	ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)
Dec-30-21 07:57AM	Forget Bargains, Play 5 Stocks With Rising P/E Instead (Zacks)
Dec-13-21 08:00AM	ENDRA Life Sciences Announces New Clinical Study Partnership with Kings College Hospital, London (Business Wire) -6.98%
Nov-29-21 08:00AM	ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study (Business Wire)
Nov-16-21 09:15AM	ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents (Business Wire) -14.29%
Nov-15-21 06:15PM	ENDRA Life Sciences Inc. (NDRA) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -5.67%
04:05PM	ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Nov-08-21 08:00AM	ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021 (Business Wire)
Oct-13-21 08:00AM	ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent (Business Wire)
Oct-05-21 08:00AM	ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference (Business Wire)
Sep-07-21 08:00AM	ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences (ACCESSWIRE)
Aug-12-21 04:05PM	ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update (ACCESSWIRE)
Aug-02-21 08:00AM	ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021 (ACCESSWIRE)
Jul-20-21 08:00AM	ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021 (ACCESSWIRE)
Jul-07-21 08:00AM	ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents (ACCESSWIRE)
Jun-25-21 05:18AM	ENDRA Life Sciences (NASDAQ:NDRA) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.) +5.53%
Jun-15-21 08:35AM	ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells (ACCESSWIRE) -6.14%
Jun-09-21 08:00AM	ENDRA Life Sciences Set to Join the Russell Microcap(R) Index (ACCESSWIRE) +5.02%
May-17-21 04:05PM	ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update (ACCESSWIRE)
May-06-21 08:00AM	ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021 (ACCESSWIRE)
May-04-21 08:30AM	ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents (ACCESSWIRE)
Apr-19-21 10:18AM	Zacks Industry Outlook Highlights: MedTech, including Natus Medical, Owens & Minor, Penumbra, Apollo Medical and ENDRA Life Sciences (Zacks) +5.05%
Apr-08-21 08:30AM	ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting (ACCESSWIRE)
Mar-25-21 04:05PM	ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update (ACCESSWIRE)

ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thornton Michael Milos	Chief Technology Officer	May 18 '23	Buy	1.65	15,000	24,750	34,139	May 22 07:30 AM
DIGIANDOMENICO ANTHONY	Director	May 02 '23	Buy	1.20	83,333	100,000	102,434	May 03 04:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NDRA

ENDRA Life Sciences Inc

Upgrade your FINVIZ experience